Adicet Bio, Inc. SEC filings ACET
Adicet Bio, Inc. has 682 filings in SEC EDGAR's recent list, going back to Oct 27, 2017. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 26.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 POS | Filing | May 13, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| S-3 | Shelf registration | Mar 12, 2026 | — |
| 424B5 | Prospectus supplement | Oct 7, 2025 | — |
| S-8 | Employee stock plan registration | Jul 25, 2025 | — |
| S-8 POS | Filing | Mar 26, 2025 | — |
| 424B5 | Prospectus supplement | Mar 18, 2025 | — |
| S-8 | Employee stock plan registration | Mar 6, 2025 | — |
| S-3 | Shelf registration | Mar 6, 2025 | — |
| 424B5 | Prospectus supplement | Mar 22, 2024 | — |
| S-8 POS | Filing | Mar 19, 2024 | — |
| S-8 | Employee stock plan registration | Mar 19, 2024 | — |
| 424B5 | Prospectus supplement | Jan 24, 2024 | — |
| 424B5 | Prospectus supplement | Jan 22, 2024 | — |
| S-8 POS | Filing | Aug 9, 2023 | — |
| S-8 | Employee stock plan registration | Aug 9, 2023 | — |
| S-8 | Employee stock plan registration | Mar 15, 2023 | — |
| 424B5 | Prospectus supplement | Nov 8, 2022 | — |
| S-3/A | Filing | Mar 16, 2022 | — |
| S-8 | Employee stock plan registration | Mar 16, 2022 | — |
| S-3 | Shelf registration | Mar 15, 2022 | — |
| 424B5 | Prospectus supplement | Dec 9, 2021 | — |
| 424B5 | Prospectus supplement | Dec 7, 2021 | — |
| S-8 | Employee stock plan registration | Aug 12, 2021 | — |
| 424B3 | Prospectus | May 21, 2021 | — |
| S-3 | Shelf registration | May 13, 2021 | — |
| S-3 | Shelf registration | Mar 12, 2021 | — |
| S-8 | Employee stock plan registration | Mar 12, 2021 | — |
| 424B5 | Prospectus supplement | Feb 11, 2021 | — |
| S-3MEF | Filing | Feb 10, 2021 | — |
| 424B5 | Prospectus supplement | Feb 10, 2021 | — |
| S-8 POS | Filing | Jan 28, 2021 | — |
| S-8 POS | Filing | Jan 28, 2021 | — |
| 424B5 | Prospectus supplement | Dec 1, 2020 | — |
| S-8 | Employee stock plan registration | Nov 12, 2020 | — |
| S-8 | Employee stock plan registration | Oct 2, 2020 | — |
| 424B5 | Prospectus supplement | Sep 21, 2020 | — |
| 424B3 | Prospectus | Aug 21, 2020 | — |
| S-4/A | Filing | Aug 19, 2020 | — |
| S-4/A | Filing | Aug 12, 2020 | — |
| S-4/A | Filing | Jul 29, 2020 | — |
| S-4 | Registration for a merger or exchange | Jun 23, 2020 | — |
| S-8 | Employee stock plan registration | Mar 12, 2020 | — |
| 424B5 | Prospectus supplement | Mar 20, 2019 | — |
| 424B5 | Prospectus supplement | Mar 18, 2019 | — |
| S-8 | Employee stock plan registration | Mar 18, 2019 | — |
| S-3 | Shelf registration | Feb 1, 2019 | — |
| S-8 | Employee stock plan registration | Jan 29, 2018 | — |
| 424B4 | Prospectus | Jan 29, 2018 | — |
| S-1/A | Amended registration statement | Jan 16, 2018 | — |
| S-1 | Registration statement | Dec 29, 2017 | — |
Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACET (Nasdaq)
- Fiscal year ends
- December 26
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1720580
- Former names
- resTORbio, Inc. (until Aug 21, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.